PMID

Data

Article Title

Organization

Discovery of a novel series of selective HCN1 blockers.

Johnson & Johnson Pharmaceutical Research & Development

SAGE-718: A First-in-Class

Sage Therapeutics

Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)

Sage Therapeutics

Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation.

Vanderbilt University Institute of Imaging Science

PYRIMIDINE OR PYRIDINE DERIVATIVES USEFUL AS HCN2 MODULATORS

King''s College London